Question

Difficulty: HardClinical Preventive Services and Screening

A 12-month-old boy is brought to the clinic for a routine well-child and preventive care visit. He has a history of perinatally acquired HIV infection. He is currently taking antiretroviral therapy and trimethoprim-sulfamethoxazole for pneumocystis prophylaxis. Laboratory studies from last week show a CD4+ T-cell percentage of 12%. His parents are concerned about his physical development. They report that he can pull himself to a standing position and cruise along the furniture, but he is unable to stand alone or walk independently. He has a mature pincer grasp and says 'mama' and 'dada' specifically to his parents. The parents inquire about his developmental progress and which scheduled vaccines he should receive today. Which of the following is the most appropriate management plan for this patient?

  1. Administer hepatitis A, pneumococcal conjugate, and Haemophilus influenzae type b vaccines; reassure the parents that his motor development is age-appropriateAnswer
  2. B
    Administer measles-mumps-rubella, varicella, and pneumococcal conjugate vaccines; reassure the parents that his motor development is age-appropriate
  3. C
    Administer hepatitis A, pneumococcal conjugate, and Haemophilus influenzae type b vaccines; refer the patient to a pediatric neurologist for motor developmental delay
  4. D
    Administer measles-mumps-rubella, varicella, and pneumococcal conjugate vaccines; refer the patient to a pediatric neurologist for motor developmental delay
  5. E
    Administer the live-attenuated rotavirus, hepatitis A, and pneumococcal conjugate vaccines; reassure the parents that his motor development is age-appropriate

Answer

Administer hepatitis A, pneumococcal conjugate, and Haemophilus influenzae type b vaccines; reassure the parents that his motor development is age-appropriate
The correct management involves recognizing normal developmental milestones and applying appropriate immunization contraindications. The patient's motor development is normal for a 12-month-old. Pulling to stand and cruising are expected milestones at this age; independent walking typically develops between 12 and 15 months. Therefore, reassurance is indicated, and a referral for motor delay is unnecessary. Regarding immunizations, the patient has severe immunosuppression from HIV, indicated by a CD4+ T-cell percentage of less than 15%. In severely immunocompromised patients, live-attenuated vaccines (such as measles-mumps-rubella and varicella) are strictly contraindicated due to the risk of vaccine-strain disseminated infection. However, inactivated vaccines (such as hepatitis A, pneumococcal conjugate, and Haemophilus influenzae type b) are safe and should be administered according to the standard schedule to provide essential preventive immunity.

Step-by-Step Solution

1
Evaluate the patient's developmental milestones compared to normal 12-month expectations.
The patient's motor (cruising), fine motor (pincer grasp), and language ('mama'/'dada' specifically) milestones are completely normal.
Cruising is age-appropriate at 12 months; independent walking is not definitively expected until 15 months.
2
Evaluate the patient's immune status based on his CD4+ T-cell percentage.
A CD4+ percentage of 12% in a 12-month-old with HIV indicates severe immunosuppression.
The threshold for defining severe immunosuppression in pediatric HIV patients is a CD4+ percentage of less than 15%.
3
Determine the appropriate immunization schedule based on the patient's immune status.
Live-attenuated vaccines are contraindicated; inactivated vaccines should be administered.
Live vaccines can cause disseminated, life-threatening infections in severely immunocompromised patients, whereas inactivated vaccines are safe and indicated.

Key Concept

Clinical Preventive Services and Screening: Developmental milestone assessment and immunization protocols in immunocompromised pediatric patients.
Estimated Time:1m 30s
Rate this question